Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$159.56 - $209.29 $4.62 Million - $6.07 Million
-28,985 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$169.75 - $207.73 $108,979 - $133,362
642 Added 2.27%
28,985 $5.47 Million
Q2 2021

Aug 16, 2021

BUY
$128.63 - $176.89 $328,392 - $451,600
2,553 Added 9.9%
28,343 $4.81 Million
Q4 2020

Feb 16, 2021

BUY
$122.97 - $147.0 $3.17 Million - $3.79 Million
25,790 New
25,790 $3.35 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Ararat Capital Management, LP Portfolio

Follow Ararat Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ararat Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Ararat Capital Management, LP with notifications on news.